申请人:Boehringer Ingelheim International GmbH
公开号:US20130225549A1
公开(公告)日:2013-08-29
The present invention relates to dihydropteridinones, their use as modulators of γ-secretase and to pharmaceutical compositions containing said compounds. In particular, the present invention relates to compounds which interfere with γ-secretase and/or its substrate and therefore modulate the formation of Aβ peptides.
本发明涉及二氢喜树碱酮,它们作为γ-分泌酶调节剂的用途以及含有该化合物的药物组合物。具体而言,本发明涉及干扰γ-分泌酶和/或其底物的化合物,因此调节Aβ肽的形成。